Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer
- DOI
- 10.3389/fimmu.2026.1866358
- Published
- 2026-07-28
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1866358,
title = {Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer},
author = {Ran An and Jianming Li and Tianhui Liu and Cunyu Tang and Hong Lu},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1866358},
url = {https://doi.org/10.3389/fimmu.2026.1866358}
}RIS
TY - JOUR TI - Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer AU - Ran An AU - Jianming Li AU - Tianhui Liu AU - Cunyu Tang AU - Hong Lu PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1866358 UR - https://doi.org/10.3389/fimmu.2026.1866358 ER -
APA
An, R., Li, J., Liu, T., Tang, C., & Lu, H. (2026). Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1866358
Source records
- crossref · retrieved 2026-09-26T03:26:12.218Z